Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer

MLA

Heshan Liu, et al. Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer. Apr. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....88ef8c12f381e22f30df64b7f57de9c2&authtype=sso&custid=ns315887.

APA

Heshan Liu, Tom R. Fitch, Alan P. Lyss, Edith A. Perez, Donald W. Northfelt, Mark W. Rodacker, Jacob B. Allred, & Timothy J. Hobday. (2014). Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer.

Chicago

Heshan Liu, Tom R. Fitch, Alan P. Lyss, Edith A. Perez, Donald W. Northfelt, Mark W. Rodacker, Jacob B. Allred, and Timothy J. Hobday. 2014. “Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....88ef8c12f381e22f30df64b7f57de9c2&authtype=sso&custid=ns315887.